hVIVO plc (LON:HVO – Get Free Report)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 28.07 ($0.36) and traded as low as GBX 25 ($0.32). hVIVO shares last traded at GBX 25.40 ($0.32), with a volume of 2,916,822 shares trading hands.
hVIVO Trading Down 5.0 %
The company has a market cap of £164.11 million, a price-to-earnings ratio of 846.67 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company’s fifty day moving average price is GBX 28.07 and its two-hundred day moving average price is GBX 28.11.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than hVIVO
- Insider Buying Explained: What Investors Need to Know
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- About the Markup Calculator
- Applied Materials Market Capitulates: Now is the Time to Buy
- Why Are These Companies Considered Blue Chips?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
